BeStock  
Stocks › Biotechnology › SRPT

Sarepta Therapeutics SRPT

US equityMarket cap rank #2908Biotechnology
$13.33 −$0.84 (-5.93%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $13.60 +2.03%
Open$13.92
Prev close$14.17
Day range$13.25 – $14.47
Volume2.25M
Market cap$1.43B
P/E (TTM)–
Dividend yield–

SRPT Stock News

Headlines matching Sarepta Therapeutics or the SRPT ticker, most recent first.

  • J.P. Morgan Maintains Sarepta Therapeutics(SRPT.US) With Hold Rating, Announces Target Price $20Market news · 30 Sep 2026 · Direct mention
  • William Blair Initiates Sarepta Therapeutics(SRPT.US) With Hold RatingMarket news · 29 Sep 2026 · Direct mention
  • Citi Maintains Sarepta Therapeutics(SRPT.US) With Sell Rating, Maintains Target Price $13Market news · 28 Sep 2026 · Direct mention
  • Needham Maintains Sarepta Therapeutics(SRPT.US) With Sell RatingMarket news · 28 Sep 2026 · Direct mention
  • J.P. Morgan Maintains Sarepta Therapeutics(SRPT.US) With Hold Rating, Raises Target Price to $23 PositiveMarket news · 2 Sep 2026 · Direct mention
  • J.P. Morgan Remains a Hold on Sarepta Therapeutics (SRPT)TipRanks · 2 Sep 2026 · Direct mention
  • J.P. Morgan Maintains Sarepta Therapeutics(SRPT.US) With Hold RatingMarket news · 15 Sep 2026 · Direct mention
  • Barclays Maintains Sarepta Therapeutics(SRPT.US) With Hold Rating, Maintains Target Price $20Market news · 8 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Sarepta Therapeutics(SRPT.US), With a Forecast Between $5 to $38Market news · 7 Aug 2026 · Direct mention
  • Evercore Maintains Sarepta Therapeutics(SRPT.US) With Hold Rating, Maintains Target Price $19Market news · 10 Aug 2026 · Direct mention
  • Wolfe Research Upgrades Sarepta Therapeutics(SRPT.US) to Buy Rating, Announces Target Price $27 PositiveMarket news · 9 Jul 2026 · Direct mention
  • Analysts' Opinions Are Mixed on These Healthcare Stocks: Vericel (VCEL), Sarepta Therapeutics (SRPT) and Neumora Therapeutics, Inc. (NMRA)TipRanks · 28 Jul 2026 · Direct mention
  • Morgan Stanley Maintains Sarepta Therapeutics(SRPT.US) With Hold Rating, Maintains Target Price $25Market news · 27 Jul 2026 · Direct mention
  • Mizuho Securities Maintains Sarepta Therapeutics(SRPT.US) With Buy Rating, Maintains Target Price $31Market news · 10 Jul 2026 · Direct mention
  • Tradr 2X Long SRPT Daily ETF: Tradr 2X Long SRPT Daily ETF - Anticipated Liquidation/Anticipated Cash Settlement Option Symbol: SRPUOCC · 4 Jun 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on SRPT.

Sign in to join the discussion.

Scroll to Top